PetIQ, Inc. (PETQ) Misses Q4 EPS by 23c, Revenues Beat; Offers FY19 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2018 Financial Results
March 11, 2019 4:05 PM EDTFourth Quarter 2018 Net Sales Increased 114% Year-Over-Year to $111.0 Million Full Year 2018 Net Sales of $528.6 Million Provides Full Year 2019 Outlook
EAGLE, Idaho, March 11, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three months and full year ended December 31, 2018.
Fourth Quarter 2018 Highlights Compared to Prior Year Period
Record fourth quarter net sales of $111.0 million, an increase of 114%;Â representing organic net sales growth of 70%Net loss of... More